Clinical Trials Directory

Trials / Recruiting

RecruitingNCT00901602

Lebanese Interhospital Pneumococcal Surveillance Program

Lebanese Interhospital Pneumococcal Surveillance Program (LIPSP)

Status
Recruiting
Phase
Study type
Observational
Enrollment
700 (estimated)
Sponsor
American University of Beirut Medical Center · Academic / Other
Sex
All
Age
1 Day
Healthy volunteers
Not accepted

Summary

Streptococcus pneumoniae (pneumococcus) is a bacterium that causes severe infections in children and adults such as meningitis, pneumonia, and blood stream infection. There are many types of these bacteria defined by the type of sugar coat that they have. These are classified as serotypes. There are common serotypes that cause severe disease and are preventable by vaccination of children. Other less common types are more difficult to prevent. The investigators aim to determine the serotypes that cause invasive pneumococcal disease in Lebanon and to study their sensitivity to different antibiotics. The investigators will collect bacterial isolates from different hospitals in Lebanon isolated from the blood or spinal fluid of patients with invasive pneumococcal disease. This information will help the investigators determine the usefulness of available pneumococcal vaccines in preventing these infections. The data will be distributed to all primary care physicians treating children in Lebanon and will be shared with the Ministry of Health.

Conditions

Timeline

Start date
2005-10-01
Primary completion
2030-10-01
Completion
2030-10-01
First posted
2009-05-14
Last updated
2023-02-03

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT00901602. Inclusion in this directory is not an endorsement.